cardiovascular disease
| 5 min read
By using extracellular vesicles to target specific neurons in the hypothalamus, scientists induced weight loss in a mouse model of obesity without altering its diet or exercise.
| 5 min read
Cardiologist Sheba Meymandi hopes to prevent the deadly cardiac effects of Chagas disease with increased screening and knowledge of the disease.
| 6 min read
CRISPR gene editing directly and indirectly drives advances in cardiovascular disease therapeutic development.
| 2 min read
Researchers built a framework to purposefully identify drug candidates for repurposing.
| 4 min read
Linda Goodman, Co-Founder and CTO of Fauna Bio, compares animal and human genomes to identify new drug targets for heart disease, obesity, and more.
| 2 min read
New York Institute of Technology secures $1.8M grant to investigate vascular decalcification
| 3 min read
The five year collaboration aims to improve treatment outcomes in cardiovascular disease management in Asian patients
| 4 min read
Patients report experiencing symptoms for more than 13 hours a day and 72 percent of patients report experiencing 10 or more symptoms despite taking calcium and vitamin D
